Michael Peter Fischbein, MD
Thoracic Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fischbein’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A63291 · Current
Licensed to practise in California · since 1997 · expires 2027-04-30 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$162,064
Medicare paid this office $162,064 for 70 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 18 | $36,041 | $2,002 |
| Repair of aortic arch with graft on heart-lung machine | 11 | $27,834 | $2,530 |
| Replacement of aortic valve through the skin and femoral artery | 16 | $9,876 | $617 |
| Exposure of underarm or upper chest artery with creation of conduit | 23 | $6,766 | $294 |
| New patient visit (30+ min) | 12 | $875 | $73 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 1-10 | None |
Who their Medicare patients are
70 Original Medicare patients in 2024. Average age 74 · Women 36% · Also on Medicaid 23% · Health risk score 1.59. At or below the middle of the specialty; the typical thoracic surgery clinician is at 1.74.
Conditions among them: High blood pressure 75% · Heart failure 70% · Coronary heart disease 66% · Atrial fibrillation 63% · Chronic kidney disease 53% · Diabetes 36% · COPD 29% · Cancer 19% · Stroke 19% · Depression 16%.
The office billed $1,317,582, Medicare allowed $202,995 and paid $162,064; for 157 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 70 | 157 | 74 | 1.59 | $1,317,582 | $162,064 |
| 2023 | 83 | 194 | 74 | 1.39 | $1,534,284 | $200,284 |
| 2022 | 92 | 199 | 73 | 1.56 | $1,501,754 | $186,099 |
| 2021 | 144 | 276 | 75 | 1.60 | $1,528,365 | $182,449 |
| 2020 | 177 | 308 | 74 | 1.48 | $1,550,302 | $167,154 |
| 2019 | 203 | 366 | 75 | 1.47 | $1,917,880 | $204,520 |
| 2018 | 246 | 407 | 76 | 1.95 | $2,417,569 | $223,712 |
| 2017 | 268 | 406 | 76 | 1.81 | $2,991,014 | $267,992 |
| 2016 | 275 | 414 | 77 | 1.46 | $2,942,165 | $268,833 |
| 2015 | 220 | 338 | 79 | 1.92 | $2,927,964 | $256,996 |
| 2014 | 246 | 375 | 79 | 1.78 | $2,668,402 | $240,910 |
| 2013 | 232 | 370 | 79 | 1.64 | $2,283,439 | $218,430 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 18 | $38,530 | $2,141 |
| Repair of aortic arch with graft on heart-lung machine | 13 | $32,824 | $2,525 |
| Replacement of aortic valve through the skin and femoral artery | 22 | $14,096 | $641 |
| Repair of aortic arch with graft | 15 | $11,528 | $769 |
| Exposure of underarm or upper chest artery with creation of conduit | 33 | $10,379 | $315 |
| New patient visit (30+ min) | 17 | $1,288 | $76 |
2022: 5 services
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 14 | $30,971 | $2,212 |
| Repair of aortic arch with graft on heart-lung machine | 13 | $30,702 | $2,362 |
| Replacement of aortic valve through the skin and femoral artery | 21 | $13,678 | $651 |
| Exposure of underarm or upper chest artery with creation of conduit | 29 | $9,051 | $312 |
| New patient visit (30+ min) | 11 | $834 | $76 |
2021: 7 services
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 11 | $26,064 | $2,369 |
| Replacement of aortic valve through the skin and femoral artery | 35 | $22,825 | $652 |
| Exposure of underarm or upper chest artery with creation of conduit | 17 | $5,429 | $319 |
| New patient visit (45+ min) | 19 | $2,465 | $130 |
| New patient visit (30+ min) | 28 | $2,089 | $75 |
| Short return visit | 26 | $879 | $28 |
| New patient visit (15+ min) | 14 | $618 | $44 |
2020: 6 services
| Replacement of aortic valve through the skin and femoral artery | 52 | $35,002 | $673 |
| Coronary artery bypass using artery graft, 1 graft | 13 | $19,226 | $1,479 |
| New patient visit (30+ min) | 42 | $2,837 | $68 |
| New patient visit (45+ min) | 21 | $2,526 | $120 |
| Short return visit | 35 | $906 | $22 |
| New patient visit (15+ min) | 17 | $749 | $44 |
2019: 9 services
| Replacement of aortic valve through the skin and femoral artery | 48 | $34,904 | $727 |
| Replacement of aortic valve on heart-lung machine | 19 | $33,489 | $1,763 |
| Coronary artery bypass using artery graft, 1 graft | 17 | $22,773 | $1,340 |
| Repair of aortic arch with graft | 11 | $9,823 | $893 |
| New patient visit (30+ min) | 72 | $4,518 | $63 |
| Short return visit | 37 | $901 | $23 |
| New patient visit (15+ min) | 18 | $829 | $46 |
| Short return visit (20+ min) | 13 | $650 | $46 |
| Harvest of vein using an endoscope | 18 | $250 | $14 |
2018: 8 services
| Replacement of aortic valve through the skin and femoral artery | 82 | $57,139 | $697 |
| Placement of graft to aorta on heart-lung machine | 12 | $31,837 | $2,653 |
| Replacement of aortic valve on heart-lung machine | 17 | $30,113 | $1,771 |
| Placement of graft to aorta on heart-lung machine | 17 | $17,771 | $1,045 |
| New patient visit (30+ min) | 71 | $4,642 | $65 |
| Short return visit (20+ min) | 30 | $1,279 | $40 |
| New patient visit (15+ min) | 23 | $968 | $42 |
| Short return visit | 34 | $706 | $19 |
2017: 9 services
| Replacement of aortic valve through the skin and femoral artery | 107 | $78,480 | $720 |
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 15 | $40,291 | $2,686 |
| Replacement of aortic valve on heart-lung machine | 21 | $35,284 | $1,680 |
| Placement of graft to aorta on heart-lung machine | 23 | $24,898 | $1,083 |
| New patient visit (30+ min) | 33 | $2,240 | $68 |
| New patient visit (15+ min) | 29 | $1,314 | $45 |
| Short return visit (20+ min) | 25 | $1,095 | $41 |
| Short return visit | 35 | $750 | $20 |
| New patient visit (10+ min) | 12 | $216 | $18 |
2016: 10 services
| Replacement of aortic valve through the skin and femoral artery | 110 | $79,838 | $719 |
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 16 | $43,069 | $2,692 |
| Replacement of aortic valve on heart-lung machine | 18 | $33,173 | $1,843 |
| Coronary artery bypass using artery graft, 1 graft | 11 | $16,106 | $1,464 |
| Placement of graft to aorta on heart-lung machine | 12 | $12,981 | $1,082 |
| New patient visit (15+ min) | 41 | $1,838 | $45 |
| Short return visit | 61 | $1,188 | $19 |
| New patient visit (30+ min) | 12 | $814 | $68 |
| Short return visit (20+ min) | 13 | $592 | $46 |
| Harvest of vein using an endoscope | 14 | $192 | $14 |
2015: 8 services
| Replacement of aortic valve by through femoral artery | 90 | $70,930 | $788 |
| Replacement of aortic valve on heart-lung machine | 22 | $42,007 | $1,909 |
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 13 | $35,078 | $2,698 |
| Coronary artery bypass using artery graft, 1 graft | 13 | $14,536 | $1,118 |
| Placement of graft to aorta on heart-lung machine | 13 | $14,090 | $1,084 |
| Short return visit | 35 | $794 | $23 |
| New patient visit (10+ min) | 27 | $642 | $24 |
| Harvest of vein using an endoscope | 11 | $150 | $14 |
2014: 8 services
| Replacement of aortic valve by through femoral artery | 83 | $65,904 | $794 |
| Replacement of aortic valve on heart-lung machine | 19 | $33,955 | $1,787 |
| Repair of ascending aorta with graft on heart-lung machine with aortic root replacement and heart reconstruction | 11 | $29,800 | $2,709 |
| Coronary artery bypass using artery graft, 1 graft | 12 | $17,833 | $1,486 |
| Replacement of aortic valve with prosthetic valve | 11 | $10,396 | $945 |
| New patient visit (15+ min) | 51 | $2,146 | $42 |
| Short return visit | 47 | $1,137 | $21 |
| New patient visit (10+ min) | 35 | $796 | $23 |
2013: 10 services
| Replacement of aortic valve on heart-lung machine | 28 | $53,051 | $1,895 |
| Replacement of aortic valve by through femoral artery | 41 | $31,517 | $769 |
| Replacement of aortic valve with prosthetic valve | 19 | $17,592 | $926 |
| Coronary artery bypass using artery graft, 1 graft | 15 | $17,528 | $1,169 |
| Implantation prosthetic aortic heart valve via catheter through chest | 12 | $11,084 | $924 |
| New patient visit (30+ min) | 53 | $3,471 | $65 |
| New patient visit (15+ min) | 55 | $2,366 | $43 |
| Short return visit (20+ min) | 28 | $1,279 | $44 |
| Short return visit | 24 | $559 | $22 |
| Harvest of vein using an endoscope | 13 | $175 | $13 |
Money from drug and device companies
$398 in 2025
| 2025 | 1 | 3 | None | $398 |
| 2024 | 1 | 1 | None | $172 |
| 2019 | 2 | 2 | None | $179 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | None | $398 | 3 payments
|
See all 3 published payments
| Edwards Lifesciences | Meals · 2025-06-28 | None | $85 |
| Edwards Lifesciences | Meals · 2025-06-28 | None | $267 |
| Edwards Lifesciences | Meals · 2025-06-27 | None | $47 |
See earlier years (2024, 2019)
2024: $172
| Abbott Laboratories | Epic | $172 | 1 payment
|
2019: $179
| Bolton Medical | Relay Plus | $149 | 1 payment
|
| Edwards Lifesciences | None | $30 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2023 | Their institution | $232,900 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2020 | Their institution | $149,066 |
| Edwards Lifesciences Corporation · Early-Tavr Trial 2016-07 · 2019 | Their institution | $128,885 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2024 | Their institution | $75,045 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2025 | Their institution | $54,059 |
| Edwards Lifesciences Corporation · Early-Tavr Trial #2016-07 · 2022 | Their institution | $53,013 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2022 | Their institution | $29,227 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2023 | Their institution | $24,296 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Tssb Lsa Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms · 2021 | Their institution | $21,280 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Tssb-Lsa Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms · 2019 | Their institution | $18,688 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2025 | Their institution | $16,400 |
| Edwards Lifesciences Corporation · Partner3 2015-08 · 2024 | Their institution | $13,858 |
| Abbott Laboratories · Portico Re-Sheathable Transcatheter Aortic Valve System US Ide Trial (Portico) · 2019 | Their institution | $13,720 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Thoracic Branch Endoprosthesis (Tbe Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta · 2022 | Their institution | $11,264 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Tssb-Lsa Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms · 2020 | Their institution | $10,504 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Tssb Bca Endoprosthesis in the Treatment of Aortic Arch Aneurysms · 2021 | Their institution | $9,280 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Thoracic Branch Endoprosthesis (Tbe Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta · 2023 | Their institution | $8,928 |
| Abbott Laboratories · Portico Re-Sheathable Transcatheter Aortic Valve System US Ide Trial (Portico) · 2020 | Their institution | $5,261 |
| Medtronic, Inc. · Perigon · 2021 | Their institution | $5,120 |
| Medtronic, Inc. · Corevalve Surtavi · 2021 | Their institution | $3,693 |
| Abbott Laboratories · Portico Re-Sheathable Transcatheter Aortic Valve System US Ide Trial (Portico) · 2021 | Their institution | $3,350 |
| Medtronic, Inc. · Corevalve Surtavi · 2023 | Their institution | $1,890 |
| Edwards Lifesciences Corporation · Partner II (2010-12) · 2024 | Their institution | $1,638 |
| Medtronic, Inc. · Corevalve Surtavi · 2025 | Their institution | $1,369 |
| Medtronic, Inc. · Corevalve Surtavi · 2024 | Their institution | $1,280 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Tssb Bca Endoprothesis in the Treatment of Aortic Arch Aneurysms · 2022 | Their institution | $1,280 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Thoracic Branch Endoprosthesis (Tbe Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta · 2024 | Their institution | $1,216 |
| W. L. Gore & Associates, Inc. · Great Global Registry for Endovascular Aortic Treatment · 2023 | Their institution | $768 |
| Medtronic, Inc. · Corevalve Surtavi · 2022 | Their institution | $640 |
| W. L. Gore & Associates, Inc. · Evaluation of the Gore Tag Tssb-Bca Endoprosthesis in the Treatment of Aortic Arch Aneurysms · 2019 | Their institution | $64 |
| Abbott Laboratories · Portico Re-Sheathable Transcatheter Aortic Valve System US Ide Trial (Portico) · 2022 | Their institution | $38 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1700811411
- Licence
- CA A63291California A63291: Current · expires 2027-04-30
- Trained
- Boston University School of Medicine, 1995
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Thoracic surgery (208G00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2006-07-11
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.